NASDAQ
Barinthus Biotherapeutics plc - American Depositary Shares (BRNS)
♥ 517 Thanks from members
Barinthus Biotherapeutics (BRNS) is advancing its all-stock merger with Clywedog Therapeutics, culminating in a UK scheme of arrangement set for September 3, 2026, which will delist BRNS ADSs and transition trading to Nasdaq under the ticker CLYD.